<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/75E77BF3-29B4-4699-9CD9-223230E8A463"><gtr:id>75E77BF3-29B4-4699-9CD9-223230E8A463</gtr:id><gtr:name>Babraham Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Clinical Biochemist</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/75E77BF3-29B4-4699-9CD9-223230E8A463"><gtr:id>75E77BF3-29B4-4699-9CD9-223230E8A463</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C9BD7B85-E2CA-4B2B-B92E-04A03E3D55C8"><gtr:id>C9BD7B85-E2CA-4B2B-B92E-04A03E3D55C8</gtr:id><gtr:firstName>Justin</gtr:firstName><gtr:surname>Rochford</gtr:surname><gtr:orcidId>0000-0002-5020-4939</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0800203"><gtr:id>6351DE6D-C5F5-4135-B4E8-A9732E2CF4D2</gtr:id><gtr:title>Elucidating the Function of BSCL2, a Critical Regulator of Human Fat Development</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800203</gtr:grantReference><gtr:abstractText>Given the high and increasing rates of obesity, the harmful effects of excess fat on health are well known. However, conditions in which fat mass is abnormally low (lipodystrophies) are much rarer and so receive far less attention. In fact, having either too much or too little body fat are each strongly associated with similar diseases such as diabetes and heart disease which are major causes of suffering and mortality. This shows that it is important for us to develop just the right amount of fat and for it to be able to work efficiently to store and release nutrients and secrete the hormones it produces appropriately. Increasing fat mass involves making new fat cells (adipocytes) from precursor cells, and carefully controlling this process is therefore critical for health. This work examines this process mainly using cells that can be turned into adipocytes in the lab and studying the genes that regulate this process. Specifically we are focussing on a gene called BSCL2 which we know is critical for making fat tissue in humans as its disruption causes almost complete lack of fat. We have recently discovered that this gene regulates the process of adipocyte formation but the precise mechanism by which it does this is not clear. This work aims to define how BSCL2 controls the formation of fat cells, to identify the proteins it interacts with to do this, and how BSCL2 itself is regulated. In this way we will learn much more about how fat cells develop. This information will not only be critical for ultimately finding ways to treat patients with this very specific, rare but devastating form of lipodystrophy, but is also extremely relevant to understanding the development and treatment of obesity.</gtr:abstractText><gtr:technicalSummary>Homozygous mutations in the gene BSCL2 cause the most severe form of congenital lipodystrophy, Berardinelli-Seip congenital lipodystrophy type 2, in which there is a near complete absence of adipose tissue. Remarkably, the mechanism whereby this occurs has remained unclear as very little is understood about the BSCL2 protein. The severity of the disease has led to speculation that BSCL2 may play a role in stem cell commitment to adipogenesis. However, the expression of BSCL2 in the brain has also led to suggestions of a centrally mediated role in fat formation. The first insights into the cellular function of BSCL2 have come through the recent identification of the yeast orthologue of BSCL2. Yeast lacking this gene fail to appropriately generate intracellular lipid droplets, and a similar phenotype was also described in fibroblasts isolated from a BSCL2 patient. However, this study did not elucidate the mechanism behind this phenomenon and the molecular role of BSCL2 remained unclear. We have now shown that BSCL2 is highly expressed in mature adipocytes, is induced during adipogenesis, and that BSCL2 expression is essential for adipocyte formation. This proposal aims to build on these data to more clearly define the role and regulation of BSCL2 in adipogenesis. Specifically the work will: 1. Characterise the effects of BSCL2 inhibition, determine how BSCL2 controls adipocyte formation, and delineate the transcriptional regulation of the BSCL2. Each of these may suggest therapeutic strategies for altering BSCL2 expression; 2. Identify new binding partners for BSCL2 and thereby give further insight into its function; 3. Attempt to rescue the effects of lipodystrophy-causing mutations in BSCL2 in vitro and so ultimately inform treatment of BSCL2 patients; 4. Determine whether polymorphisms in BSCL2 may influence adiposity and metabolic disease traits in the general population. This research will give exciting molecular insights into this devastating form of lipodystrophy. As BSCL2 is a key regulator of adipogenesis, a process whose perturbation is at the heart of other conditions of altered fat mass, this research is also of major relevance to highly prevalent disorders including obesity and associated conditions such as diabetes and cardiovascular disease.</gtr:technicalSummary><gtr:fund><gtr:end>2012-08-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>357803</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Babraham Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Investigating the role of DGKdelta in adipocyte develpment and function</gtr:description><gtr:id>783A1DEC-B2C9-4AB1-9406-E9A184E0D9D8</gtr:id><gtr:impact>Manuscript in preparation</gtr:impact><gtr:partnerContribution>Analysis of affected cellular lipid species by lipodomics</gtr:partnerContribution><gtr:piContribution>Cellular studies of DGKdelta in differentiating adipocytes</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Analysis of seipin and its binding proteins by AFM</gtr:description><gtr:id>59C7DD2C-1E78-4C08-8085-55341813A130</gtr:id><gtr:impact>Initial work now published. Continued collaboration ongoing with 2 further manuscripts in preparation for submission</gtr:impact><gtr:partnerContribution>Expression of proteins and analysis of complexes by Atomic Force Microscopy</gtr:partnerContribution><gtr:piContribution>Generation of constructs to be used in experiments to determine the stoichiomettry and geometry of seipin and its interacting partners in complexes by Atomic Force Microscopy</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cambridge Institute for Medical Research (CIMR)</gtr:department><gtr:description>Identifying novel binding partners for BSCL2/Seipin</gtr:description><gtr:id>2F13912F-0C07-4301-8362-898B8D6E0D37</gtr:id><gtr:impact>Identified interactions currently being confirmed and function determined.</gtr:impact><gtr:partnerContribution>Proteomic analysis of peptides associated with immunoprecipitated seipin isolated from differentiating adipocytes</gtr:partnerContribution><gtr:piContribution>Confirmation and determination of the function of seipin interacting partners identified through the proteomic screen</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Cambridge Science Festival, 2011, 2012 and 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>00441F14-2C0D-4042-9ED2-94F532678617</gtr:id><gtr:impact>Large groups of families and interested individuals attended our display/event entitled 'fantastic fat' with interactive games and displays. Significant interest, discussion and positive feedback.

Sixth form pupils have visit to the lab for work experience</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Student from Nuffield Bursary Scheme</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>ACEBB9E0-951E-4849-A781-55DDC9BC8412</gtr:id><gtr:impact>Hosted a Nuffield student for 5 weeks in the lab and took part in a &amp;quot;Celebration&amp;quot; afternoon for the regional students from the scheme at which work from the lab was presented.

Student now interested in pursuing a career in science.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to clinical geneticists Aberdeen Royal Infirmary</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B5DCA119-AEA4-4C87-B29D-479AFFE5A4C0</gtr:id><gtr:impact>Talk gave rise to discussion and questions.

I was asked by a family member of an attendee who is a school student if they could join my laboratory for a summer placement.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Engagement Talk at Satrosphere Aberdeen ads part of Aberdeen Techfest Sept 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0D4A3A48-9C5E-401C-ACE0-3ABC34ECA175</gtr:id><gtr:impact>Talk entitled &amp;quot;Good or bad: Can we learn to love our fat?&amp;quot; attended by around 50 members of the public with Q&amp;amp;A afterwards


Requests for further similar talks in future.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to Grampian Branch of The Society of Chiropodists and Podiatrists.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B28347D2-C769-422B-898B-27727D91F1C8</gtr:id><gtr:impact>Talk sparked discussion after the presentation

Participants reported that the talk had improved their understanding of factors affecting body weight and metabolic health which would inform their approach to patient advice and care.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>56000</gtr:amountPounds><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fellowship for Advanced Researchers</gtr:description><gtr:end>2012-11-02</gtr:end><gtr:fundingOrg>Swiss National Science Foundation</gtr:fundingOrg><gtr:id>1CD66155-9611-4CDB-90BF-A0C5B045E9DA</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2010-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0F1A23BC-C7C7-4E52-B44E-991DAF53280C"><gtr:id>0F1A23BC-C7C7-4E52-B44E-991DAF53280C</gtr:id><gtr:title>Identification and Characterisation of a Novel Pathogenic Mutation in the Human Lipodystrophy Gene AGPAT2 : C48R: A Novel Mutation in AGPAT2.</gtr:title><gtr:parentPublicationTitle>JIMD reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/30a5989f7e19cf1c404e166ef5e8b250"><gtr:id>30a5989f7e19cf1c404e166ef5e8b250</gtr:id><gtr:otherNames>Ramanathan N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2192-8304</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C5A4CE9A-AC12-4EE2-8A9D-E3C377B81AFE"><gtr:id>C5A4CE9A-AC12-4EE2-8A9D-E3C377B81AFE</gtr:id><gtr:title>Seipin oligomers can interact directly with AGPAT2 and lipin 1, physically scaffolding critical regulators of adipogenesis.</gtr:title><gtr:parentPublicationTitle>Molecular metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8402fc134ee4de6dede4701e9fcacc66"><gtr:id>8402fc134ee4de6dede4701e9fcacc66</gtr:id><gtr:otherNames>Talukder MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2212-8778</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7DA175A1-9B06-4A59-8A36-484493672DC3"><gtr:id>7DA175A1-9B06-4A59-8A36-484493672DC3</gtr:id><gtr:title>Adipogenesis at a glance.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/08e03efebfa0980c579cfa3efa21a5b0"><gtr:id>08e03efebfa0980c579cfa3efa21a5b0</gtr:id><gtr:otherNames>Lowe CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/90D0F6FD-9960-4652-83AD-0DE7E136E18D"><gtr:id>90D0F6FD-9960-4652-83AD-0DE7E136E18D</gtr:id><gtr:title>Increased lipolysis and altered lipid homeostasis protect ?-synuclein-null mutant mice from diet-induced obesity.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eb9cafcfa42756592e306486da9a5a3f"><gtr:id>eb9cafcfa42756592e306486da9a5a3f</gtr:id><gtr:otherNames>Millership S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4A7D5702-417D-45E2-89F5-E3CB7F63D96F"><gtr:id>4A7D5702-417D-45E2-89F5-E3CB7F63D96F</gtr:id><gtr:title>The human lipodystrophy protein seipin is an ER membrane adaptor for the adipogenic PA phosphatase lipin 1.</gtr:title><gtr:parentPublicationTitle>Molecular metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87585ee842c9ceae206460a773fe3c6c"><gtr:id>87585ee842c9ceae206460a773fe3c6c</gtr:id><gtr:otherNames>Sim MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2212-8778</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5A5A4B7F-5651-4B26-9144-795469F0F06C"><gtr:id>5A5A4B7F-5651-4B26-9144-795469F0F06C</gtr:id><gtr:title>Analysis of naturally occurring mutations in the human lipodystrophy protein seipin reveals multiple potential pathogenic mechanisms.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87585ee842c9ceae206460a773fe3c6c"><gtr:id>87585ee842c9ceae206460a773fe3c6c</gtr:id><gtr:otherNames>Sim MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3676B785-4D3B-41A9-AADD-A0F8D09D8393"><gtr:id>3676B785-4D3B-41A9-AADD-A0F8D09D8393</gtr:id><gtr:title>Setting the tone: reactive oxygen species and the control of appetitive melanocortin neurons.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c59fd45df1017447e1dc4d6cd6ea6ef6"><gtr:id>c59fd45df1017447e1dc4d6cd6ea6ef6</gtr:id><gtr:otherNames>Rochford JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/03C94840-65C7-45D7-8203-48F1789ED516"><gtr:id>03C94840-65C7-45D7-8203-48F1789ED516</gtr:id><gtr:title>Molecular mechanisms controlling human adipose tissue development: insights from monogenic lipodystrophies.</gtr:title><gtr:parentPublicationTitle>Expert reviews in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c59fd45df1017447e1dc4d6cd6ea6ef6"><gtr:id>c59fd45df1017447e1dc4d6cd6ea6ef6</gtr:id><gtr:otherNames>Rochford JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1462-3994</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E767559B-652E-418A-A149-F2E2FC8A2675"><gtr:id>E767559B-652E-418A-A149-F2E2FC8A2675</gtr:id><gtr:title>C/EBP transcription factors regulate SREBP1c gene expression during adipogenesis.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ef0707dc5088899ece82e3ae227d5a12"><gtr:id>ef0707dc5088899ece82e3ae227d5a12</gtr:id><gtr:otherNames>Payne VA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/034E1C6A-EA72-450F-8593-F71DD92F78F8"><gtr:id>034E1C6A-EA72-450F-8593-F71DD92F78F8</gtr:id><gtr:title>Analysis of TBC1D4 in patients with severe insulin resistance.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b32061dbcabfddafc235fd4e6c303aa3"><gtr:id>b32061dbcabfddafc235fd4e6c303aa3</gtr:id><gtr:otherNames>Dash S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/23C9B9D6-0193-43E0-AA26-5A0CD683206D"><gtr:id>23C9B9D6-0193-43E0-AA26-5A0CD683206D</gtr:id><gtr:title>Neuroanatomical characterisation of the expression of the lipodystrophy and motor-neuropathy gene Bscl2 in adult mouse brain.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/96fa99b2823233fd6d15a2dd11725b41"><gtr:id>96fa99b2823233fd6d15a2dd11725b41</gtr:id><gtr:otherNames>Garfield AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/772FB172-84C7-4DE7-BD2E-3B6C13E410A5"><gtr:id>772FB172-84C7-4DE7-BD2E-3B6C13E410A5</gtr:id><gtr:title>Analyzing the functions and structure of the human lipodystrophy protein seipin.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87585ee842c9ceae206460a773fe3c6c"><gtr:id>87585ee842c9ceae206460a773fe3c6c</gtr:id><gtr:otherNames>Sim MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F23E7019-AEE5-4176-BE76-BE68B8E0D219"><gtr:id>F23E7019-AEE5-4176-BE76-BE68B8E0D219</gtr:id><gtr:title>?-synuclein is a novel player in the control of body lipid metabolism.</gtr:title><gtr:parentPublicationTitle>Adipocyte</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eb9cafcfa42756592e306486da9a5a3f"><gtr:id>eb9cafcfa42756592e306486da9a5a3f</gtr:id><gtr:otherNames>Millership S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2162-3945</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/90DE8495-3385-4EDF-9F6D-79BDF45BF20B"><gtr:id>90DE8495-3385-4EDF-9F6D-79BDF45BF20B</gtr:id><gtr:title>Knockdown of diacylglycerol kinase delta inhibits adipocyte differentiation and alters lipid synthesis.</gtr:title><gtr:parentPublicationTitle>Obesity (Silver Spring, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/08e03efebfa0980c579cfa3efa21a5b0"><gtr:id>08e03efebfa0980c579cfa3efa21a5b0</gtr:id><gtr:otherNames>Lowe CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1930-7381</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E346869B-FB26-443C-A1E8-D8757DDE8F7A"><gtr:id>E346869B-FB26-443C-A1E8-D8757DDE8F7A</gtr:id><gtr:title>Lipodystrophy: metabolic insights from a rare disorder.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/120893d6db842ae2fac96265727b0fb4"><gtr:id>120893d6db842ae2fac96265727b0fb4</gtr:id><gtr:otherNames>Huang-Doran I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E196068F-0F91-4805-815A-DB6E488DB931"><gtr:id>E196068F-0F91-4805-815A-DB6E488DB931</gtr:id><gtr:title>Investigating the involvement of the ATF6a pathway of the unfolded protein response in adipogenesis.</gtr:title><gtr:parentPublicationTitle>International journal of obesity (2005)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/08e03efebfa0980c579cfa3efa21a5b0"><gtr:id>08e03efebfa0980c579cfa3efa21a5b0</gtr:id><gtr:otherNames>Lowe CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0307-0565</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3D896F05-2CEC-4465-9F31-69D21185992B"><gtr:id>3D896F05-2CEC-4465-9F31-69D21185992B</gtr:id><gtr:title>Mouse models of lipodystrophy and their significance in understanding fat regulation.</gtr:title><gtr:parentPublicationTitle>Current topics in developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c59fd45df1017447e1dc4d6cd6ea6ef6"><gtr:id>c59fd45df1017447e1dc4d6cd6ea6ef6</gtr:id><gtr:otherNames>Rochford JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0070-2153</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800203</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>A77DAE3A-499B-4F46-971D-6C82F51F9C2E</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Stroke</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>67</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>